Medtronic PLC (MDT)

Last Closing Price: 91.38 (2022-07-01)

Company Description

Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $31.69B
Net Income (Most Recent Fiscal Year) $5.04B
PE Ratio (Current Year Earnings Estimate) 16.42
PE Ratio (Trailing 12 Months) 16.26
PEG Ratio (Long Term Growth Estimate) 2.34
Price to Sales Ratio (Trailing 12 Months) 3.87
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 2.33
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) 12.00
Pre-Tax Margin (Trailing 12 Months) 17.41%
Net Margin (Trailing 12 Months) 15.90%
Return on Equity (Trailing 12 Months) 14.50%
Return on Assets (Trailing 12 Months) 8.28%
Current Ratio (Most Recent Fiscal Quarter) 1.86
Quick Ratio (Most Recent Fiscal Quarter) 1.49
Debt to Common Equity (Most Recent Fiscal Quarter) 0.39
Inventory Turnover (Trailing 12 Months) 2.28
Book Value per Share (Most Recent Fiscal Quarter) $39.30
Earnings per Share (Most Recent Fiscal Quarter) $1.52
Earnings per Share (Most Recent Fiscal Year) $5.55
Diluted Earnings per Share (Trailing 12 Months) $3.73
Stock
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Common Shares Outstanding 1.34B
Free Float 1.34B
Market Capitalization $122.59B
Average Volume (Last 20 Days) 5.66M
Beta (Past 60 Months) 0.77
Percentage Held By Insiders (Latest Annual Proxy Report) 0.47%
Percentage Held By Institutions (Latest 13F Reports) 80.23%
Annual Dividend (Based on Last Quarter) $2.72
Dividend Yield (Based on Last Quarter) 2.98%